F. Nava

Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe

N. Wright, R. Littlewood, F. Meroueh, 2019, BMC Public Health.

HCR-20v3. Assessing risk for violence

A. Schimmenti, S. Ferracuti, R. Catanesi, 2019 .

Hepatitis delta is a public health concern in the community setting: The role of prison health care units in limiting the spread of infection in general population

C. Pilerci, M. Cristofoletti, Giulia Bassetti, 2022, MISSION.

Insufficient access to harm reduction measures in prisons in 5 countries (PRIDE Europe): a shared European public health concern

M. Jauffret-Roustide, P. Carrieri, W. Vanderplasschen, 2015, BMC Public Health.

Prison health is a public health: Management of Sars-CoV-2 outbreak in an Italian prison

G. Padovan, P. Orcamo, F. Nava, 2021, MISSION.

HIV treatment and care among Italian inmates: a one-month point survey

S. Carbonara, S. Babudieri, R. Monarca, 2015, BMC Infectious Diseases.

Infection diseases in the prisons: A public health warming. Priority action to protect general community

A. Alberti, A. Cattelan, L. Craxì, 2022, MISSION.

Analysis of Patients’ Characteristics and Treatment Profile of People Who Use Drugs (PWUDs) with and without a Co-Diagnosis of Viral Hepatitis C: A Real-World Retrospective Italian Analysis

A. Mangia, F. Foschi, M. Puoti, 2023, Therapeutics and clinical risk management.